Upcoming updates
for 2026-2027
Quick Take Vol. 83
Managing Catatonia: From Clinical Assessment to Effective Intervention – Interview
GI Side Effects and Antidepressants
Quick Take Vol. 84
Addiction Psychopharmacology in Patients with Medical Comorbidities
Nutritional Psychiatry – Interview
Tricyclic Antidepressants in Psychiatry
Use of Long-Acting Injectable Antipsychotics in Schizophrenia – Interview
Management of Psychotropic-Induced Sexual Dysfunction
Quick Take Vol. 85
Antidepressant-Induced Excessive Sweating
Pharmacotherapy of Alcohol Use Disorder – Interview
Quick Take Vol. 86
Posttraumatic Stress Disorder Psychopharmacology Algorithm (Update)
Side Effects of Antidepressants Part 5 (Hyperprolactinemia)
Antidepressant Withdrawal Effects and Safe Deprescribing – Interview
Prescribing for mental health conditions in patients with physical illness
Quick Take Vol. 87
Cardiac Effects of Antidepressants: A Clinical Guide
Quick Take Vol. 88
Treatment-Resistant Anxiety Disorders: Focus on GAD, PD, and SAD
Metabolic Psychiatry
Ophthalmologic Effects of Antidepressants: A Clinical Guide
Lamotrigine Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects
Quick Take Vol. 89
Nutraceuticals and Phytoceuticals for Mood and Anxiety Disorders
Ketamine and Esketamine
Valproate Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects
Pharmacotherapies for Stimulant Use Disorder (Update)
Quick Take Vol. 90
Pharmacotherapy of treatment-resistant depression – Interview
Lithium Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects
Pharmacotherapy for Cannabis Use Disorder
Mood and Anxiety Disorders During Perimenopause – Interview
Quick Take Vol. 91
Buspirone Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects
Updates on Geriatric Psychopharmacology – Interview
Quick Take Vol. 92
Pharmacological Management of Primary Insomnia
Atomoxetine Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects
Methylphenidate Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects
Psychotropic-Induced Movement Disorders and Cognitive Side Effects (Update) – Interview
Switching Antipsychotics in Clinical Practice 2026 update
Quick Take Vol. 93
Amphetamines Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects
Pharmacotherapy Bipolar Depression: Strategies for Everyday Management – Interview
Drug-Drug Interactions in Psychopharmacology.
Quick Take Vol. 94
ADHD Medications: A Comprehensive Formulations Guide
CME Information
Physicians – CME Accreditation Statement
The activities below have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy LLC is accredited by the ACCME to provide AMA PRA Category 1 Credits™ for physicians.
This CME program issues AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Nursing professionals – CME Accreditation Statement
The activities below have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy LLC is accredited by the ACCME to provide AMA PRA Category 1 Credits™ for physicians.
This CME program issues AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
The ANCC accepts AMA PRA Category 1 Credit(s)™ as Contact Hours, under this calculation: 1 CME = 1 Contact Hour.
Physician assistants – CME Accreditation Statement
The activities below have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy LLC is accredited by the ACCME to provide AMA PRA Category 1 Credits™ for physicians.
This CME program issues AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Self Assessment for MOC – Accreditation Statement
- Psychopharmacology Institute Self-Assessment Program 2025
Dates: April 1, 2025 – April 1, 2028
The American Board of Psychiatry and Neurology has reviewed the Psychopharmacology Institute Self-Assessment Program 2025 and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.
- Psychopharmacology Institute Self-Assessment, 2023- Part 1
Dates: January 1, 2023 – January 1, 2026
The American Board of Psychiatry and Neurology has reviewed the Psychopharmacology Institute Self-Assessment, 2023- Part 1 and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.
- Psychopharmacology Institute Self-Assessment Program 2024
Dates: April 1, 2024 – April 1, 2027
The American Board of Psychiatry and Neurology has reviewed the Psychopharmacology Institute Self-Assessment Program 2024 and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.